Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

Novo Nordisk works with Hims & Hers ... hundreds of thousands of doses of their versions of Novo's obesity and diabetes drugs while the FDA said the medicines were in short supply.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...

"We're really pleased about the level of interest to access branded Wegovy and to start to sort of catch people as they come off of compounded medicine ... in Novo Nordisk's diabetes drug ...

Shares of Hims & Hers soared 40% in premarket trading Tuesday, while Novo ... compounded medicine," he said. Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes ...